Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation
This study developed and validated a nomogram that accurately predicted the risk for early recurrence after PA-TACE treatment in patients with HCC at a high risk for recurrence. Importantly, the nomogram identified PA-TACE as a key prognostic factor with significant clinical utility.
Authors
- Jianan Feng (ORCID: https://orcid.org/0000-0001-5139-1695)
- Zhoubin Feng (ORCID: https://orcid.org/0009-0001-5217-1835)
- Mingxin Pan (ORCID: https://orcid.org/0000-0002-3979-5571)
- Yuyan Xu (ORCID: https://orcid.org/0000-0003-3335-1248)
- Kaihang Zhong
- Yaohong Wen
- Guolin He (ORCID: https://orcid.org/0000-0001-8032-1434)
- Cheng Zhang (ORCID: https://orcid.org/0000-0002-4570-1762)
- Chunming Wang (ORCID: https://orcid.org/0000-0001-9185-9678)
- Lei Cai (ORCID: https://orcid.org/0000-0003-1658-7996)
- Shunjun Fu (ORCID: https://orcid.org/0000-0001-5318-5908)
- Hongkun Tan
Institutions
- Zhujiang Hospital (CN)
- Huizhou Central People's Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s12876-025-04023-6
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project
- Basic and Applied Basic Research Foundation of Guangdong Province